RGEN Repligen Corp. Gross Profitability Margin

Official company branding of Repligen Inc. (RGEN)

Repligen Corporation is developing strategic alliances with global pharma behemoths to accelerate the release of biologics. Strict certification within the filtration niche creates robust barriers to entry for competitors. Demand for vaccine production equipment continues to grow steadily. The adjusted gross margin demonstrates the business's financial resilience, and its value has stabilized at 48.90.

Gross Profitability: repligen.com (RGEN) for 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Repligen Corp. (RGEN)

- stock price and consensus target price:
Fundamental valuation:RGEN - Repligen Corp
Manufactured product of Repligen Corp

The automation of filtration and chromatography processes in biopharmaceuticals allows Repligen Corporation (RGEN) to optimize production costs, which directly impacts operational efficiency. This metric measures the profit margin after deducting direct costs, demonstrating the business's ability to monetize its technological advantage, while analyzing the gross margin trend helps investors identify the risks of overpaying for the asset during peaks in profitability.

Main competitors

Return on Gross Profit Tempus AI Inc|QGEN (Qiagen NV) - Gross Margin|Return on Gross Profit Ionis Pharma (IONS)|Gross Margin RNA|CRSP - Gross Profit Margin|GeneDx - Return on Gross Profit|Gross Profit Rate RARE|Beam Tx - Gross Margin|SRPT - Gross Margin|TWST (Twist Bio) - Return on Gross Profit|Gross Return on Sales TXG|Return on Gross Profit NTLA|Stoke Therapeutics Inc (STOK) - Return on Sales by Gross Profit|Gross Margin BLFS|Gross Profitability WVE (Wave Life Sciences Corp)|Gross Profitability Maze Therapeutics MAZE|Gross Profit Rate SION|PRME - Gross Profitability|Return on Sales by Gross Profit Taysha TSHA|QURE: Gross Margin|Return on Gross Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Gross Margin|solidbio.com (SLDB) - Return on Sales by Gross Profit|Gross Profitability Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Gross Return on Sales|Benitec Biopharma - Return on Gross Profit|DSGN: Gross Return on Sales|RCKT: Return on Gross Profit|FDMT - Gross Margin|LXEO: Gross Margin|Korro Bio Inc. - Gross Profit Rate|EDIT (editasmedicine.com) - Gross Margin|Gross Profitability SLN|Gross Profitability ProQR Therapeutics NV (PRQR)|Codexis - Gross Return on Sales|Gross Profitability Sangamo SGMO|NAUT: Gross Return on Sales|MGX: Return on Gross Profit|Gross Profit Margin Precision BioSciences|GBIO (generationbio.com) - Return on Gross Profit|Gross Profit Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Gross Margin|Gross Return on Sales IMNN (Imunon, Inc.)|Gross Margin PHIO|MBIO - Gross Profit Margin|Gross Margin RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Gross Profit Margin|Applied DNA - Gross Margin|Gross Profit Margin Bluebird Bio|ImmunoPrecise (IPA) - Gross Profitability|Gross Profitability Margin OMGA (Omega)|Gross Profitability Singular Genomics Systems|Gross Profit Margin regulusrx.com RGLS|Gross Profitability Syros Pharmaceuticals Inc. (SYRS)|Return on Sales by Gross Profit Codex DNA|Gross Profitability TRACON TCON|Unity Biotechnology, Inc - Gross Profitability